Jacobson & Schmitt Advisors added 6,661 shares of Kinsale Capital Group in the fourth quarter; the estimated trade value was $2.72 million based on quarterly average prices.
The fund's quarter-end stake value rose by $1.37 million, reflecting both additional shares and price movement.
The fund held 42,894 shares in Kinsale Capital Group worth $16.78 million after the trade.
Jacobson & Schmitt Advisors reported the purchase of 6,661 Kinsale Capital Group (NYSE:KNSL) shares in a January 20 SEC filing, an estimated $2.72 million trade based on quarterly average pricing.
According to a January 20 SEC filing, Jacobson & Schmitt Advisors, LLC increased its position in Kinsale Capital Group (NYSE:KNSL) by 6,661 shares during the fourth quarter. The estimated transaction value was approximately $2.72 million, based on the average closing price for the quarter. As of December 31, the position was valued at $16.78 million, up $1.37 million from the prior quarter, reflecting both the share addition and price change.
The Kinsale Capital Group stake accounted for 2.82% of the fund’s 13F reportable AUM after the trade.
Top holdings after the filing:
As of January 20, shares of Kinsale Capital Group were priced at $405.12, down 7.6% over the prior year and underperforming the S&P 500 by about 20 percentage points
| Metric | Value |
|---|---|
| Revenue (TTM) | $1.80 billion |
| Net income (TTM) | $474.09 million |
| Dividend yield | 0.17% |
| Price (as of market close 1/20/26) | $405.12 |
Kinsale Capital Group is a specialty insurer with a national footprint and a focus on complex, hard-to-place risks. The company leverages deep underwriting expertise and a disciplined approach to risk selection to drive profitable growth. Its broker-driven distribution model and emphasis on niche markets provide a competitive edge in the property and casualty insurance sector.
At under 3% of reported assets, this addition fits neatly alongside a portfolio already anchored by diversified ETFs, mega-cap tech, and steady compounders, suggesting this is a quality tilt rather than a thematic swing. What makes the move notable, however, is the underlying business consistency at a time when many insurers are struggling to defend margins.
The company’s latest quarter underscored why disciplined specialty underwriting still works. Net income climbed to $141.6 million, or $6.09 per diluted share, up 24% year over year, and underwriting income reached $105.7 million. Meanwhile, gross written premiums grew 8.4% to $486.3 million, even as competition weighed on certain property lines. The company also repurchased $20 million worth of shares.
Shares have lagged the broader market over the past year, but fundamentals have not seemingly followed the same script. For long-term investors, this looks like a calculated allocation to a high-ROE insurer that continues to generate capital internally, repurchase shares, and compound book value without stretching for growth.
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 930%* — a market-crushing outperformance compared to 192% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of January 21, 2026.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Amphenol, and Kinsale Capital Group. The Motley Fool recommends FirstService. The Motley Fool has a disclosure policy.